Self-reported Breast Implants and Connective-Tissue Diseases in Female Health Professionals
- 28 February 1996
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 275 (8) , 616-621
- https://doi.org/10.1001/jama.1996.03530320040032
Abstract
Objective. —To evaluate the association of breast implants with connectivetissue diseases. Design and Participants. —Retrospective cohort study of 395 543 female health professionals who completed mailed questionnaires for potential participation in the Women's Health Study. A total of 10830 women reported breast implants and 11 805 reported connective-tissue diseases between 1962 and 1991. Cox proportional hazards regression models were used in analyses. Main Outcome Measure. —Self-reported connective-tissue diseases. Results. —Compared with women who did not report breast implants, the relative risk (RR) of the combined end point of any connective-tissue disease among those who reported breast implants was 1.24(95% confidence interval, 1.08 to 1.41,P=.0015). With respect to the individual diseases, the finding for other connectivetissue diseases (including mixed) was statistically significant (P=.017), the findings for rheumatoid arthritis, Sjögren's syndrome, dermatomyositis or polymyositis, or scleroderma were of borderline statistical significance (.05<P<.10), and the finding for systemic lupus erythematosus was not statistically significant (P=.44). There were no clear trends in RR with increasing duration of breast implants. Conclusion. —These self-reported data from female health professionals are compatible with prior reports from other cohort studies that exclude a large hazard, but do suggest small increased risks of connective-tissue diseases among women with breast implants. The very large sample size makes chance an unlikely explanation for the results, but bias due to differential overreporting of connective-tissue diseases or selective participation by affected women with breast implants remains a plausible alternative explanation. The major contribution of this and other observational analytic studies has been to exclude large risks of connective-tissue diseases following breast implants. (JAMA. 1996;275:616-621)Keywords
This publication has 13 references indexed in Scilit:
- Silicone Breast Implants and the Risk of Connective-Tissue Diseases and SymptomsNew England Journal of Medicine, 1995
- Breast implants, rheumatoid arthritis, and connective tissue diseases in a clinical practiceJournal of Clinical Epidemiology, 1995
- Breast silicone implants and risk of systemic lupus erythematosusJournal of Clinical Epidemiology, 1994
- Re: Breast Implants, Cancer, and Systemic SclerosisJNCI Journal of the National Cancer Institute, 1994
- A pathophysiological examination of the biophysics and bioreactivity of silicone breast implantsSeminars in Arthritis and Rheumatism, 1994
- Risk of Connective-Tissue Diseases and Other Disorders after Breast ImplantationNew England Journal of Medicine, 1994
- Scleroderma and augmentation mammoplasty ‐ a causal relationship?Australian and New Zealand Journal of Medicine, 1994
- The Silicone Controversy — When Will Science Prevail?New England Journal of Medicine, 1992
- Breast Implants — Protection or Paternalism?New England Journal of Medicine, 1992
- AN EPIDEMIOLOGICAL STUDY OF SCLERODERMA IN THE WEST MIDLANDSRheumatology, 1988